etoposide 20mg/ml concentrate for solution for infusion (250mg/12.5ml)
accord healthcare limited - etoposide - concentrate for solution for infusion - etoposide 20 mg - antineoplastic agents
etoposide 20mg/ml concentrate for solution for infusion (400mg/20ml)
accord healthcare limited - etoposide - concentrate for solution for infusion - etoposide 20 mg - antineoplastic agents
etoposide 20mg/ml concentrate for solution for infusion (500mg/25ml)
accord healthcare limited - etoposide - concentrate for solution for infusion - etoposide 20 mg - antineoplastic agents
etoposide 20mg/ml concentrate for solution for infusion (1000mg/50ml)
accord healthcare limited - etoposide - concentrate for solution for infusion - etoposide 20 mg - antineoplastic agents
etoposide teva
abic marketing ltd, israel - etoposide - concentrate for solution for infusion - etoposide 20 mg/ml - etoposide - etoposide - hodgkin's disease. malignant (non-hodgkin's) lymphomas, especially of the histiocytic variety.acute non-lymphocytic leukemia. management of refractory testicular tumors and of small cell lung cancer.
etoposide
accord healthcare limited - etoposide - concentrate for soln for inf - 20 mg/ml - etoposide
etoposide 20 mg/ml concentrate for soln for inf
cipla (eu) limited - etoposide - concentrate for soln for inf - 20 mg/ml - podophyllotoxin derivatives - it is indicated in adults for the management of: resistant non-seminomatous testicular tumours in combination with other chemotherapeutic agents; small cell lung cancer, in combination with other chemotherapeutic agents; acute monoblastic leukaemia (aml m5) and acute myelomonoblastic leukaemia (aml m4) when standard induction therapy has failed (in combination with other chemotherapeutic agents).
etoposide 20 mg/ml concentrate for solution for infusion
fresenius kabi oncology plc - etoposide - concentrate for solution for infusion - 20 milligram(s)/millilitre - podophyllotoxin derivatives; etoposide
cisplatin mylan concentrate for solution for infusion 1mg/ml (50ml vial)
mylan s.a.s. 117 allee des parcs, 69800 saint priest, france - cisplatin - concentrate for solution for infusion - cisplatin 1 mg/ml - antineoplastic agents
mitoxantrone 2 mg/ml concentrate for solution for infusion (5ml)
accord healthcare ireland ltd euro house, euro business park, little island cork, t45 k857, ireland - mitoxantrone - concentrate for solution for infusion - mitoxantrone 2 mg/ml - antineoplastic agents